ClinicalTrials.Veeva

Menu
M

Medical Investigations, Inc. | Little Rock, AR

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dapagliflozin
Semaglutide
Darusentan
MK-0616
Vildagliptin
Linagliptin
Metformin
Retatrutide
LY3437943
PF-04634817

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 17 total trials

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight (TRIUMPH-1)

The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master pr...

Active, not recruiting
Overweight
Obesity
Drug: Retatrutide
Drug: Placebo

This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of enlicitide decanoate, an oral proprotein convertase subtilisin/...

Enrolling
Arteriosclerosis
Hypercholesterolaemia
Drug: Placebo
Drug: Enlicitide Decanoate

The objective of the study is to assess the safety and effectiveness of MiniMed™ 780G system in adult subjects with insulin-requiring type 2 diabetes...

Active, not recruiting
Type 2 Diabetes Treated with Insulin
Device: MiniMed™ 780G Insulin Pump system

Trial sponsors

Medtronic logo
Lilly logo
Novo Nordisk logo
AstraZeneca logo
Boehringer Ingelheim logo
Gilead Sciences logo
Merck Sharp & Dohme (MSD) logo
Mylan logo
Novartis logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems